Monoclonal antibody for human hematopoietic glycoproteins and method
CA 1257210 A · Owner: Sloan-Kettering Institute For Cancer Research A.K.A. Sloan-Kettering Institute · Inventors: Ogata, Shun-Ichiro; Dupont, Bo; Collins, Nancy
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention concerns a new monoclonal antibody (mAb) 4C, recognizing a specific antigen, Leu 200 found in human, hematopoietic tissues. The monoclonal antibody precipitates a series of glycoproteins (Leu 200) with a molecular weight range of about 190,000 to 230,000 from both T- and B-cell lines. The series of glycoproteins resolves into four discrete glycoprotein bands, the distribution of which varies according to the cell lines. Bands 3 and 4 predominate in a majority of T-cells whereas band 2 predominates in B cells. Thus, a Leu 200 antigen subset distribution is possible with mAb 4C. Bands 1 2, 3, 4 have, apparent molecular weights of 230K 215K, 205K, and 90K, respectively, with …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted July 11, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 11, 2006.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.